Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The viral hepatitides.

R H Purcell

    Hospital Practice
    |July 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    New hepatitis B vaccines and chemotherapy offer improved control. Researchers are actively seeking a marker for non-A, non-B hepatitis following its transmission to animals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.

    Journal of virology·2014
    Same author

    Serological evidence for a hepatitis e virus-related agent in goats in the United States.

    Transboundary and emerging diseases·2012
    Same author

    Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles.

    Journal of viral hepatitis·2009
    Same author

    Hepatitis E: an emerging awareness of an old disease.

    Journal of hepatology·2008
    Same author

    Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.

    Journal of immunological methods·2007
    Same author

    A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA.

    Epidemiology and infection·2007
    Same journal

    Cri du chat and Potter syndromes: a decision to abort.

    Hospital practice·1992
    Same journal

    Who decides when care is futile?

    Hospital practice·1991
    Same journal

    Withholding and withdrawing life support.

    Hospital practice·1991
    Same journal

    Of dead brains, living wills, and autonomy.

    Hospital practice·1991
    Same journal

    Partner notification for HIV control.

    Hospital practice·1990
    Same journal

    Promiscuity and public health: some clinical and ethical issues.

    Hospital practice·1990
    See all related articles

    Area of Science:

    • Hepatology
    • Virology
    • Immunology

    Background:

    • Hepatitis B virus (HBV) remains a significant global health concern.
    • Hepatitis A virus (HAV) incidence is decreasing in the United States.
    • Non-A, non-B hepatitis (NANBH) poses a diagnostic challenge, with recent transmission to animal models.

    Purpose of the Study:

    • To explore advancements in hepatitis B control through vaccines and chemotherapy.
    • To address the ongoing challenge of diagnosing and managing non-A, non-B hepatitis.
    • To highlight the significance of identifying a reliable marker for non-A, non-B hepatitis.

    Main Methods:

    • Review of current therapeutic strategies for hepatitis B.
    • Analysis of epidemiological trends for hepatitis A in the U.S.

    Related Experiment Videos

  • Discussion of recent developments in non-A, non-B hepatitis research, including animal models.

    • Main Results:

    • Vaccines and chemotherapy are emerging as potent tools for hepatitis B management.
    • Declining incidence of hepatitis A in the U.S. suggests successful public health interventions.
    • Successful transmission of non-A, non-B hepatitis to animals facilitates marker development.

    Conclusions:

    • The armamentarium for controlling hepatitis B is expanding.
    • Continued vigilance and research are necessary for non-A, non-B hepatitis.
    • The identification of a non-A, non-B hepatitis marker is a critical next step.